Loading…
Based on limited metadata, GliSODin Skin Nutrients received an FDA Warning Letter on May 18, 2018, regarding a product classified as "Other" (not a traditional drug, device, or conventional dietary supplement category). Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined, though they likely relate to product claims, manufacturing practices, or regulatory classification issues. The issuing FDA office is not specified in the available metadata, limiting clarity on which regulatory division initiated the action.